Pages that link to "Q39554174"

The following pages link to Suppression of inflammation response by a novel A₃ adenosine receptor agonist thio-Cl-IB-MECA through inhibition of Akt and NF-κB signaling (Q39554174):

Displaying 12 items.

• A₃ adenosine receptor allosteric modulator induces an anti-inflammatory effect: in vivo studies and molecular mechanism of action (Q34412639) (← links)
• Cytokines: roles in atherosclerosis disease progression and potential therapeutic targets (Q36064353) (← links)
• Atherosclerosis and interferon-γ: new insights and therapeutic targets (Q38126725) (← links)
• Adenosine regulation of the immune response initiated by ischemia reperfusion injury (Q38490402) (← links)
• Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases (Q39004042) (← links)
• Therapeutic potentials of adenosine receptors agonists and antagonists in colitis; Current status and perspectives (Q39404449) (← links)
• A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy (Q39418010) (← links)
• Activation of adenosine A3 receptor alleviates TNF-α-induced inflammation through inhibition of the NF-κB signaling pathway in human colonic epithelial cells (Q39470550) (← links)
• Interferon-γ: Promising therapeutic target in atherosclerosis (Q42713922) (← links)
• Adenosine Receptors As Drug Targets for Treatment of Pulmonary Arterial Hypertension (Q47130813) (← links)
• Impairment of adenosine A3 receptor activity disrupts neutrophil migratory capacity and impacts innate immune function in vivo. (Q52630285) (← links)
• Targeting the A 3 adenosine receptor to treat cytokine release syndrome in cancer immunotherapy (Q61805929) (← links)